Verrica Pharmaceuticals Inc

-0.74 (-11.82%)
5:10:29 PM EDT: $4.31 -1.25 (-22.41%)
Earnings Announcements

Verrica Pharmaceuticals Reports Q1 Non-GAAP Loss Per Share $0.25

Published: 05/09/2022 13:47 GMT
Verrica Pharmaceuticals Inc (VRCA) - Verrica Pharmaceuticals Reports First Quarter 2022 Financial Results.
Q1 Non-GAAP Loss per Share $0.25.
Verrica Pharmaceuticals - Believes Existing Cash, Cash Equivalents and Marketable Securities Sufficient to Support Planned Operations Into Q3 of 2022.
Q1 Earnings per Share View $-0.47 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.22 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $2.08 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.